123 related articles for article (PubMed ID: 29226720)
21. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
22. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
23. Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog.
Mujoo K; Watanabe M; Khokhar AR; Siddik ZH
Prostate; 2005 Jan; 62(1):91-100. PubMed ID: 15389812
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis.
Liou SF; Lin HH; Liang JC; Chen IJ; Yeh JL
Toxicology; 2009 Feb; 256(1-2):13-24. PubMed ID: 19056458
[TBL] [Abstract][Full Text] [Related]
25. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway.
Li HX; Gao JM; Liang JQ; Xi JM; Fu M; Wu YJ
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):711-7. PubMed ID: 25903858
[TBL] [Abstract][Full Text] [Related]
27. Lycopodine triggers apoptosis by modulating 5-lipoxygenase, and depolarizing mitochondrial membrane potential in androgen sensitive and refractory prostate cancer cells without modulating p53 activity: signaling cascade and drug-DNA interaction.
Bishayee K; Chakraborty D; Ghosh S; Boujedaini N; Khuda-Bukhsh AR
Eur J Pharmacol; 2013 Jan; 698(1-3):110-21. PubMed ID: 23142370
[TBL] [Abstract][Full Text] [Related]
28. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
Aghaei M; Karami-Tehrani F; Panjehpour M; Salami S; Fallahian F
Prostate; 2012 Mar; 72(4):361-75. PubMed ID: 21656837
[TBL] [Abstract][Full Text] [Related]
29. Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP.
Zhao H; Zhu C; Qin C; Tao T; Li J; Cheng G; Li P; Cao Q; Meng X; Ju X; Shao P; Hua L; Gu M; Yin C
Biochem Biophys Res Commun; 2013 Mar; 432(2):320-5. PubMed ID: 23399562
[TBL] [Abstract][Full Text] [Related]
30. Formononetin induces apoptosis in PC-3 prostate cancer cells through enhancing the Bax/Bcl-2 ratios and regulating the p38/Akt pathway.
Zhang X; Bi L; Ye Y; Chen J
Nutr Cancer; 2014; 66(4):656-61. PubMed ID: 24666255
[TBL] [Abstract][Full Text] [Related]
31. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism].
Lin F; Yan W; Wen T; Wu GY
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of synergistic induction of apoptosis by the combination therapy with hyperthermia and cisplatin in prostate cancer cells.
Zhang JF; Yan XM; Lan B; Lei YR; Li XH; Gao S; Guo YF; Guo F
Biochem Biophys Res Commun; 2016 Oct; 479(2):159-165. PubMed ID: 27524236
[TBL] [Abstract][Full Text] [Related]
34. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
35. Betaine suppresses cell proliferation by increasing oxidative stress-mediated apoptosis and inflammation in DU-145 human prostate cancer cell line.
Kar F; Hacioglu C; Kacar S; Sahinturk V; Kanbak G
Cell Stress Chaperones; 2019 Sep; 24(5):871-881. PubMed ID: 31368044
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
37. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
38. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Cancer Lett; 2011 Jul; 306(2):142-50. PubMed ID: 21429659
[TBL] [Abstract][Full Text] [Related]
39. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
[TBL] [Abstract][Full Text] [Related]
40. Effects of dihydroxy gymnemic triacetate (DGT) on expression of apoptosis associated proteins in human prostate cancer cell lines (PC3).
Pon Nivedha R; Selvaraj J; Lalitha KG; Rajalakshmi M
J Recept Signal Transduct Res; 2015; 35(6):605-12. PubMed ID: 26053511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]